AMPHADASE Trademark

Trademark Overview

On Friday, February 25, 2005, a trademark application was filed for AMPHADASE with the United States Patent and Trademark Office. The USPTO has given the AMPHADASE trademark a serial number of 76632115. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, July 21, 2025. This trademark is owned by Amphastar Pharmaceuticals, Inc.. The AMPHADASE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation used as an adjuvant to increase the absorption and dispersion of other injected drugs; for hypodermoclysis and as an adjunct in subcutaneous urography for improving resorption of radiopaque agents
amphadase

General Information

Serial Number76632115
Word MarkAMPHADASE
Filing DateFriday, February 25, 2005
Status800 - REGISTERED AND RENEWED
Status DateMonday, July 21, 2025
Registration Number3057031
Registration DateTuesday, February 7, 2006
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparation used as an adjuvant to increase the absorption and dispersion of other injected drugs; for hypodermoclysis and as an adjunct in subcutaneous urography for improving resorption of radiopaque agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 14, 2005
Primary Code005
First Use Anywhere DateMonday, November 1, 2004
First Use In Commerce DateMonday, November 1, 2004

Trademark Owner History

Party NameAmphastar Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRancho Cucamonga, CA 91730
Party NameAmphastar Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRancho Cucamonga, CA 91730
Party NameAmphastar Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRancho Cucamonga, CA 91730

Trademark Events

Event DateEvent Description
Wednesday, October 26, 2005NOTICE OF PUBLICATION
Monday, March 14, 2005NEW APPLICATION ENTERED
Tuesday, September 20, 2005ASSIGNED TO EXAMINER
Wednesday, September 21, 2005EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 21, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 22, 2005EXAMINER'S AMENDMENT MAILED
Friday, September 23, 2005ASSIGNED TO LIE
Friday, September 30, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 9, 2012NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, November 15, 2005PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, March 8, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 8, 2012TEAS SECTION 8 RECEIVED
Tuesday, April 10, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 11, 2012POST REGISTRATION ACTION MAILED - SEC. 8
Thursday, June 21, 2012REGISTERED - SEC. 8 (6-YR) FILED
Monday, July 9, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, June 21, 2012TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Saturday, February 7, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, June 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 20, 2015TEAS SECTION 8 & 9 RECEIVED
Saturday, February 6, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, February 6, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, February 6, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, February 6, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, January 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 7, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, February 24, 2025TEAS SECTION 8 & 9 RECEIVED
Wednesday, June 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 12, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 21, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 21, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, July 21, 2025REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Monday, July 21, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

amphadase subcutaneous adjunct hypodermoclysis urography improving agents radiopaque resorption drugs injected